本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Travere Therapeutics, Inc.

16.38
-0.5300-3.13%
盘后16.380.00000.00%16:53 EDT
成交量:99.19万
成交额:1,635.07万
市值:14.55亿
市盈率:-5.90
高:17.12
开:17.05
低:16.30
收:16.91
数据加载中...
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/24

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities